Sat.May 28, 2022 - Fri.Jun 03, 2022

BioMarin delays planned FDA filing for hemophilia gene therapy

Bio Pharma Dive

BioMarin now expects to resubmit its approval application to the FDA by the end of September, the latest regulatory setback for the company's closely watched treatment

Digital health is overrated but there is a future

World of DTC Marketing

The continued emphasis on digital health is overrated but digital health will become an integral part of total patient care. To become a vital part of patient care, digital health providers need to provide the medical community with studies that show their value to patient outcomes.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Scaling new heights with new research showing how plants can grow at altitude


A new study has found that plant species are adapted to the altitude where they grow by ‘sensing’ the oxygen levels that surround them. Credit: Cristian Miño A new study has found that plant species are adapted to the altitude where they grow by ‘sensing’ the oxygen levels that surround them.

Could virtual reality become an essential tool for healthcare education?

Pharma Phorum

The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public.

Nurses 114

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Bio Pharma Dive

Backed by $200 million in funding and led by biotech veteran Samantha Truex, Upstream is developing a clinical-stage inflammatory disease drug acquired from Astellas last year

Insurance companies putting profits ahead of patients

World of DTC Marketing

Five of America’s largest health insurers reported more than $11bn in profits in the second quarter – a decline from the same period last year when the Covid-19 pandemic helped drive sky-high profits yet they are having more of a say on patients’ treatments even when HCPs disagree.

More Trending

mRNA tech ‘reason for hope’ on path to HIV vaccine

BioPharma Reporter

With mRNA tech achieving major success against COVID-19, the initiation of trials into vaccination against HIV is creating discussion amid a potential breakthrough in the prevention of the disease. Bio Developments

Trials 108

Bristol Myers' autoimmune drug shows potential in lupus

Bio Pharma Dive

Positive Phase 2 results could help boost company executives' arguments that the drug, called deucravacitinib and under FDA review in psoriasis, will become a top-seller

Drugs 269

Why online marketing is so essential for pharma

World of DTC Marketing

There’s quite a debate in the CPG world about the investment in digital marketing. While some are increasing their digital budgets, does a pancake syrup company need to spend much money? However, with pharma brands, online is essential to a successful marketing strategy.

Understanding the health and environmental risks of microplastics


Studies have shown that tiny plastic pieces are nearly everywhere — in the air, water, food and even inside the human body — but it’s unclear what risks nano- and microplastics pose to the environment or to human health.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Monkeypox: The vaccine landscape

BioPharma Reporter

Interest in vaccines against monkeypox is growing as the outbreak spreads around the world. The arsenal includes existing smallpox vaccines and potential new monkeypox specific mRNA vaccines. Bio Developments

GSK wagers $2.1B on Affinivax and its next-generation pneumonia vaccine

Bio Pharma Dive

The deal is the second acquisition for GSK since April and gives the company access to an experimental shot that’s meant to surpass new products from Pfizer and Merck & Co

FDA grants speedy review to Dupixent rare skin disease

Pharma Phorum

Sanofi and Regeneron should hear from the FDA in the autumn whether it will approve their blockbuster immunology drug Dupixent as a therapy for rare skin disease prurigo nodularis (PN).

Synthesis of tetraphenylammonium, a phantom ion whose existence had not been confirmed


[Background] Credit: Kanazawa University [Background] Since the benzene ring is a representative constituent of organic compounds, a structure consisting only of a common element plus the benzene ring is considered to be one of the most fundamental chemical skeletons.


Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Boosting innovation in antibacterials: Pitfalls and potential solutions

BioPharma Reporter

A well-funded and appropriately rewarded biotech ecosystem is needed for the next generation of antibacterials to reach the clinic and beyond, according to BIOâs State of Innovation in Antibacterial Therapeutics report. Bio Developments

Bristol Myers bets $4B on Turning Point and its targeted cancer drugs

Bio Pharma Dive

Dive Brief: Bristol Myers Squibb is buying biotech Turning Point Therapeutics, announcing Friday a $4.1 billion deal that will give the pharmaceutical company an experimental drug that targets mutations found in lung cancer and other solid tumors. The deal values Turning Point at $76 a sh

Drugs 247

At ESMO, three studies show promise of antibody-drug conjugates in breast cancer

Pharma Phorum

The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of cancer researchers just had their own gathering, as breast cancer researchers came together in person for the first time since the start of the pandemic at the ESMO Breast Cancer congress.

Portable sensor technology aims to quickly detect foodborne contaminants outside the lab


An international team led by a University of Massachusetts Amherst food and environmental virologist has received a $750,000 USDA National Institute of Food and Agriculture (NIFA) partnership grant to develop and test portable, rapid biosensors capable of detecting noroviruses and mycotoxins in foods and agricultural products.

How to Attract and Keep Top Talent in the Pharma Industry


The increased resignation of employees is making it difficult for companies to keep up with production and meet deadlines. Here are the best ways to attract and keep top talent in the pharma industry

Roche SMA drug approved in youngest infants, challenging Novartis and Biogen

Bio Pharma Dive

Evrysdi, the only oral drug for the neurodegenerative disorder, can now be used to treat babies younger than 2 months who have been identified through newborn screening

Drugs 242

Blood drawing robot heading for pivotal trials

Pharma Phorum

In future, blood samples may be taken by an autonomous robot rather than a healthcare professional – if Dutch developer Vitestro can get its prototype approved for marketing.

How we choose to end deforestation will impact future emissions


The Glasgow Leaders’ Declaration on Forests and Land Use signed at COP26 represents a commitment by leaders representing over 85% of the world’s forests to halt and reverse deforestation and land degradation by 2030. But could the declaration’s ambitions be too ambiguous?

Genentech funnels $12m into increasing health care diversity

Outsourcing Pharma

Through its Health Equity and Diversity in STEM Innovation Fund, the biotech is looking to increase equity in care and diversify the scientific workforce. Patient centricity


Former AbbVie executive Severino joins Flagship-backed startup as CEO

Bio Pharma Dive

Severino left the pharma company in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup

Pfizer will exit GSK consumer health JV after spinout

Pharma Phorum

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July.

Grain boundaries go with the flow


HOUSTON – (June 6, 2022) – Rice University engineers who mimic atom-scale processes to make them big enough to see have modeled how shear influences grain boundaries in polycrystalline materials.

Lilly invests $2.1bn in new Indiana manufacturing sites

BioPharma Reporter

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County. Upstream Processing

FDA extends review of Amylyx ALS drug, delaying approval decision

Bio Pharma Dive

The agency said it wanted more time to assess additional clinical trial data submitted by Amylyx, and set a new decision date of Sept. 29 for the closely watched treatment

As cases rise, WHO says monkeypox risk is “moderate”

Pharma Phorum

The World Health organisation’s latest assessment of the monkeypox outbreak is that it poses a moderate threat to public health, as cases of the infection continue to rise.

A novel path for sustainable photon upconversion with non-precious metals


Sustainable chemical applications need to be able to employ renewable energy sources, renewable raw materials, and earth-abundant elements.

Pfizer opens access to portfolio for low-income countries

BioPharma Reporter

The company will provide its current and future portfolio of patented medicines to 45 lower-income countries, but the move is not without controversy. Markets & Regulations

Regeneron buys control of cancer drug Libtayo from Sanofi

Bio Pharma Dive

The biotech, which has been partnered with Sanofi for years, will pay $900 million upfront to gain sole control of the cancer immunotherapy

Drugs 169

GSK said to be close to finding partner for science cluster in UK

Pharma Phorum

GlaxoSmithKline is reportedly close to finding a development partner for a major new investment project in the UK that will see a new bioscience cluster built near its research centre in Stevenage.

Researchers establish a profile of the COVID-19 deceased based on the analysis of 140 cases of complete autopsies


Men aged between 60 and 77 with Diffuse Alveolar Damage (DAD) –acute lung injury– in proliferative phase.